National Bankshares Issues Positive Forecast for Maricann Group (CNSX:MARI) Stock Price

Maricann Group (CNSX:MARI) had its price target boosted by National Bankshares from $13.25 to $15.00 in a research report released on Thursday,BayStreet.CA reports.

Separately, Royal Bank Of Canada lifted their price objective on shares of Maricann Group from $6.00 to $16.00 in a research note on Wednesday, December 10th. Three analysts have rated the stock with a Buy rating, Based on data from MarketBeat.com, Maricann Group currently has an average rating of “Buy” and a consensus target price of $14.10.

Maricann Group Stock Performance

Maricann Group has a fifty-two week low of $0.87 and a fifty-two week high of $3.60.

About Maricann Group

Maricann Group Inc, formerly Danbel Industries Corporation, is a Canada-based integrated producer and distributor of marijuana for medical purposes. As one of approximately 43 companies with a federal license to cultivate cannabis and one of approximately 30 independent licensed producers with a federal license to process and distribute cannabis, the Company’s services a patient base with more than 8,000 registered patients. The Company is undertaking an expansion of the cultivation and support facilities to support existing and future patient growth.